Rabeprazole and Olanzapine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Olanzapine (olanzapine). Common drug interactions include neutropenia among females and thrombocytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Olanzapine. It is created by eHealthMe based on reports of 204 people who take the same drugs from the FDA, and is updated regularly.
What is Rabeprazole?
Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.
204 people who take Rabeprazole and Olanzapine together, and have interactions are studied.
What are the common drug interactions of Rabeprazole and Olanzapine, by gender? *
What are the common drug interactions of Rabeprazole and Olanzapine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Rabeprazole and Olanzapine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rabeprazole (31,689 reports)
- Olanzapine (69,242 reports)
Browse all drug interactions of Rabeprazole and Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rabeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olanzapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and olanzapine (the active ingredients of Rabeprazole and Olanzapine, respectively), and Rabeprazole and Olanzapine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Alli cause Thrombocytopenia Aggravated? - 3 seconds ago
- Drug interactions of Granisetron Hydrochloride and Tacrolimus - 13 seconds ago
- Could Heparin Sodium cause Confusion? - 15 seconds ago
- Could Fentanyl Citrate cause Swelling? - 16 seconds ago
- Could Fish Oil cause Abdominal Infection? - 18 seconds ago
- Could Omnipaque 140 cause Bradycardia? - 21 seconds ago
- Could Lamotrigine cause Bankruptcy? - 21 seconds ago
- Drug interactions of Valproate Sodium and Depakene - 31 seconds ago
- Could Pantoprazole Sodium cause Dislocation Of Vertebra? - 31 seconds ago
- Could Naproxen cause Sinus Pain? - 44 seconds ago